Media
Our latest press releases and resources for media
Here you will find a range of resources including our latest and archived press releases, information on our social media channels, and our photo and video library.
Key information
2021 Full year and fourth quarter results announcement
We will announce our full year and fourth quarter 2021 results at 12:00 GMT, 07:00 EST on Wednesday 9 February.
Following the announcement there will be a webcast hosted by Emma Walmsley, CEO, and other members of CET at 14:00 GMT, 09:00 EST.
Press releases for media
- Tony Wood appointed Chief Scientific Officer designate, GSK
- Update - GSK Consumer Healthcare
- GSK and Vir Biotechnology announce United States government agreement to purchase additional supply of sotrovimab, authorised for the early treatment of COVID-19
- ViiV Healthcare announces US FDA approval of Apretude (cabotegravir extended-release injectable suspension), the first and only long-acting injectable option for HIV prevention
GSK Twitter
-
GSK @GSK
Sobering analysis showing scale of #AMR and impact of drug-resistant infections. Urgent action is needed to use existing antibiotics wisely, and to spur innovation into new medicines and vaccines, to help us all get ahead of AMR together. twitter.com/TheLancet/stat…
about 4 days ago -
GSK @GSK
“Growing up I didn’t see people like me aspiring to become a doctor or scientist.” Janaiya shares what inspired her and how GSK is using the science of our immune systems to develop cancer treatments that lead to more personalised medicines. #ItsInOurGenes
about 5 days ago
New GSK Investor update
Emma Walmsley, CEO, and other members of CET hosted a virtual investor update on Wednesday 23 June.
The update provided a clear view of the strategy for New GSK, its outlook for growth and the opportunities we see for shareholder value creation.
